Nawar A. Latif, MD, MPH, MSCE
Assistant Professor of Obstetrics and Gynecology at the Hospital of the University of Pennsylvania
Attending, Gynecologic Oncology, Department of Obstetrics and Gynecology, Pennsylvania Hospital, Philadelphia, PA
Attending, Gynecologic Oncology, Department of Obstetrics & Gynecology, Hospital of the University of Pennsylvania, Philadelphia, PA
Associate Program Director, Gynecologic Oncology Fellowship
Director, Center for Surgical Excellence in Gynecology and Gynecologic Oncology
Department: Obstetrics and Gynecology
Contact information
Jordan Center for Gynecologic Oncology at Penn Perelman Center for Advanced Medicine
3400 Civic Center Blvd.
3rd Floor West
Philadelphia, PA 19104
3400 Civic Center Blvd.
3rd Floor West
Philadelphia, PA 19104
Email:
nawar.latif@uphs.upenn.edu
nawar.latif@uphs.upenn.edu
Education:
MD
University of Baghdad, 2002.
MPH (Master of Public Health, Health Policy and Administration, Fulbright scholarship grant)
University of Illinois at Chicago (UIC), 2009.
MSCE (Masters of Science in Clinical Epidemiology)
Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, 2016.
Permanent linkMD
University of Baghdad, 2002.
MPH (Master of Public Health, Health Policy and Administration, Fulbright scholarship grant)
University of Illinois at Chicago (UIC), 2009.
MSCE (Masters of Science in Clinical Epidemiology)
Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, 2016.
Selected Publications
Nasioudis D, Gysler S, Latif NA, Giuntoli RL 2nd, Kim SH, Ko EM: Incidence of lymph node metastases in patients with apparent early-stage endometrioid ovarian carcinoma. Int J Gynecol Cancer Page: 35(6):101897, Jun 2025.Mulugeta-Gordon L, Gysler S, Latif NA, Ko EM, Giuntoli RL 2nd, Kim SH, Nasioudis: Quality of adjuvant radiation therapy and impact on the survival of patients with lymph node-positive squamous cell carcinoma of the vulva. Int J Gynecol Cancer Page: 35(6):101748, June 2025.
Tubridy E, Gysler S, Latif NA, Ko EM, Giuntoli RL 2nd, Kim SH, Nasioudis D: Role of lymphadenectomy for apparent early-stage low-grade serous ovarian carcinoma. Int J Gynecol Cancer 35(5):101798, May 2025.
Nasioudis D, Labban N, Gysler S, Ko EM, Giuntoli RL 2nd, Kim SH, Latif NA: Outcomes of Radical Hysterectomy for Early-Stage Cervical Carcinoma, with or without Prior Cervical Excision Procedure. Cancers (Basel) 16(11):2051, May 2025.
Labban N, Li S, Ahmed M, Nandish N, Torigian D, Udupa J, Tong Y, Gysler S, Latif N.: Optimal biomarkers derived from preoperative CT scans to predict postoperative morbidity in patients with ovarian cancer. Poster presentation. The Society of Gynecologic Oncology Annual Meeting, March 2025. Poster presentation. The Society of Gynecologic Oncology Annual Meeting. Mar 2025.
Nasioudis D, Latif NA, Gysler S, Giuntoli RL 2nd, Kim SH, Ko EM: Premature adoption of adjuvant chemotherapy for locally advanced cervical carcinoma before the OUTBACK trial: cautionary tale on outcomes. Int J Gynecol Cancer 34(12):1874-1880, Dec 2024.
Labban N, Li S, Ahmed M, Nandish N, Torigian D, Udupa J, Tong Y, Gysler S, Latif N. : Optimal biomarkers derived from preoperative CT scans to predict postoperative morbidity in patients with ovarian cancer. Oral presentation. Mid-Atlantic Gynecologic Oncology Society Conference. Atlanta, GA. Oct 2024.
Nasioudis D, Labban N, Latif N, Gysler S, Cory L, Kim S, Giuntoli RL 2nd, Ko EM: Role of immunotherapy for lymph node positive vulvar melanoma: utilization and outcomes. Int J Gynecol Cancer 33(9):1347-1353, Sep 2024.
Nasioudis D, Gysler S, Latif NA, Giuntoli RL 2nd, Kim SH, Ko EM: Role of systematic lymphadenectomy at the time of interval debulking surgery for patients with advanced-stage epithelial ovarian carcinoma who achieved complete gross resection. Int J Gynecol Cancer 34(7):969-974, Jul 2024.
Nasioudis D, Gysler S, Latif N, Cory L, Giuntoli RL 2nd, Kim SH, Simpkins F, Martin L, Ko EM : Molecular landscape of ERBB2/HER2 gene amplification among patients with gynecologic malignancies; clinical implications and future directions. Gynecol Oncol 180:1-5, Jan 2024.